STAT3 and graft versus host disease: STAT3 deficiency in donor T cells augments host-tissue PD-L1/PD-1 signaling–mediated inhibition of the GSH/Myc pathway, leading to metabolic dysfunction of T cells that infiltrate GVHD target tissues.